Crossmark

Enhanced antitumor activity of atorvastatin and luteolin, with or without doxorubicin, in a solid Ehrlich carcinoma mouse model: modulation of ABC transporters, telomerase, and cancer stem cells

Crossref DOI link: https://doi.org/10.1007/s12032-026-03257-y

Published Online: 2026-03-20

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Al-Ashmawy, Ghada M. https://orcid.org/0000-0003-2225-1671
El-Ashmawy, Nahla E. https://orcid.org/0000-0002-0908-8147
Hamada, Omnia B. https://orcid.org/0000-0002-1106-4072
Khedr, Naglaa F. https://orcid.org/0000-0003-4539-8940
Funding

Funding for this research was provided by:

Tanta University
License Information

Text and Data Mining valid from 2026-03-20

Version of Record valid from 2026-03-20
More Information

Article History

Received: 7 October 2025

Accepted: 13 January 2026

First Online: 20 March 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below